The COVID-19 vaccination programme provides all those living in Aotearoa New Zealand with the best protection against the worst outcomes of the COVID-19 disease.
The vaccination programme has evolved over the past few years, with three different versions of the mRNA vaccine Comirnaty now used for most people. An adjuvanted recombinant protein vaccine, Nuvaxovid, is also available for those aged 12 years and over as an alternative primary course and can be used as a first booster or additional booster dose for those aged 18 years or over.
Everyone over the age of 12 years can receive two doses of the monovalent Comirnaty 30mcg grey cap vaccine [primary]. First and subsequent booster doses are also available using the bivalent Comirnaty 15/15mcg grey cap vaccine for those who meet the eligibility criteria.
The Comirnaty 10mcg orange cap vaccine is available for children aged 5 to 11 years and is a lower dose and smaller volume than the grey cap vaccines. Two doses are required for best protection.
Comirnaty 3mcg maroon cap vaccine is limited to young children aged between 6 months and 4 years of age who are at highest risk of severe infection if they were to catch COVID-19, such as those with severe immunocompromise or with complex and/or multiple health conditions.
COVID-19 Immunisation clinical toolkit
A summary of current guidelines, including links to current IMAC and Te Whatu Ora resources, for COVID-19 vaccinators. View the toolkit here.
View our information and guidance here.
On behalf of Te Whatu Ora, IMAC provides education and training courses for those administering COVID-19 vaccines or otherwise contributing to the programme. The course selection will depend upon the scope of your role.
Different roles and pathways
View information on the different roles in the immunisation workforce here.
COVID-19 programme-specific courses
View IMAC's COVID-19 courses here.